The role of entecavir in the treatment of chronic hepatitis B

Entecavir (ETV) is a potent and selective inhibitor of hepatitis B virus replication. In HBeAg-positive and HBeAg-negative lamivudine-naïve patients with chronic hepatitis B (CHB), treatment with ETV at a dose of 0.5 mg daily is associated with a more potent viral suppression, a higher rate of bioch...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimou, Evangelini, Papadimitropoulos, Vasilios, Hadziyannis, Stephanos J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387288/
https://www.ncbi.nlm.nih.gov/pubmed/18516259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387288/
https://www.ncbi.nlm.nih.gov/pubmed/18516259

Ejemplares similares